AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35982138 — intervention group
Group type: EXPERIMENTAL
Intervention: High emotion control (H‐EC) training condition
Number of subjects: 0
Study 35982138 — intervention group
Group type: COMPARATOR
Intervention: Low emotion control (L‐EC) training condition
Number of subjects: 0
Study 35982138 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with reported ADHD symptoms
Number of subjects: 0
Study 35982138 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study 33206131 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block with spinal morphine
Number of subjects: 924
Study 33206131 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block
Number of subjects: 924
Study 32506860 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin wrist‐ankle acupuncture (WAA) + Fluoxetine
Number of subjects: 105
Study 32506860 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick wrist‐ankle acupuncture (WAA) + Fluoxetine
Number of subjects: 105
Study 32506860 — intervention group
Group type: COMPARATOR
Intervention: Sham wrist‐ankle acupuncture (WAA) + Fluoxetine
Number of subjects: 105
Study 35347429 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime-walking group
Number of subjects: 81
Study 35347429 — intervention group
Group type: EXPERIMENTAL
Intervention: Night-time-walking group
Number of subjects: 81
Study 35347429 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun-exposure-only group
Number of subjects: 81
Study 35347429 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study 35347429 — intervention group
Group type: EXPERIMENTAL
Intervention: All intervention groups
Number of subjects: 81
Study 33434907 — intervention group
Group type: EXPERIMENTAL
Intervention: Lying-flat head positioning
Number of subjects: 8285
Study 33434907 — intervention group
Group type: COMPARATOR
Intervention: Sitting-up head positioning
Number of subjects: 8285
Study 32646462 — intervention group
Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa (CFA) with 300 UI rFSH and 150 UI rLH in long agonist protocol
Number of subjects: 0
Study 32646462 — intervention group
Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa (CFA) with 300 UI rFSH and 150 UI rLH in short antagonist protocol
Number of subjects: 0
Study 32646462 — intervention group
Group type: COMPARATOR
Intervention: No-CFA protocol
Number of subjects: 0
Study 35140009 — intervention group
Group type: EXPERIMENTAL
Intervention: No postoperative x-ray (intervention group)
Number of subjects: 316
Study 35140009 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative x-ray (control group)
Number of subjects: 316
Study 35140009 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 316
Study 34076580 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional messages
Number of subjects: 89
Study 34076580 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated messages
Number of subjects: 89
Study 34076580 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling personality types
Number of subjects: 89
Study 34076580 — intervention group
Group type: COMPARATOR
Intervention: Logical messages
Number of subjects: 89
Study 34076580 — intervention group
Group type: COMPARATOR
Intervention: No messages
Number of subjects: 89
Study 35229427 — intervention group
Group type: EXPERIMENTAL
Intervention: Teneligliptin
Number of subjects: 100
Study 35229427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35395080 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab + radiotherapy (cohort A)
Number of subjects: 40
Study 35395080 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab alone (cohort B)
Number of subjects: 40
Study 35395080 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab + standard bevacizumab (cohort B2)
Number of subjects: 40
Study 35395080 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab + low-dose bevacizumab (cohort B3)
Number of subjects: 40
Study 35395080 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab + bevacizumab (cohort C)
Number of subjects: 40
Study 35395080 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone use
Number of subjects: 40
Study 35395080 — intervention group
Group type: EXPERIMENTAL
Intervention: CD8+Ki67+T cells at day 15
Number of subjects: 40
Study 35395080 — intervention group
Group type: EXPERIMENTAL
Intervention: TMB and IAS
Number of subjects: 40
Study 33979451 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine (FFA) at 0.4 mg/kg/day (n=2) or 0.7 mg/kg/day (n=4; maximum: 26 mg/day) for a mean duration of 5.3 months (range: 2–9 months)
Number of subjects: 6
Study 33979451 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine (FFA)
Number of subjects: 6
Study 32144531 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative sinusectomy (S)
Number of subjects: 58
Study 32144531 — intervention group
Group type: COMPARATOR
Intervention: Excision and paramedian primary closure (PC)
Number of subjects: 58
Study 33279157 — intervention group
Group type: EXPERIMENTAL
Intervention: Presintered cobalt-chromium (Co-Cr) fixed partial dentures
Number of subjects: 12
Study 33279157 — intervention group
Group type: EXPERIMENTAL
Intervention: Presintered zirconia fixed partial dentures
Number of subjects: 12
Study 33279157 — intervention group
Group type: EXPERIMENTAL
Intervention: Premolar with Co-Cr
Number of subjects: 12
Study 33279157 — intervention group
Group type: EXPERIMENTAL
Intervention: Molar with zirconia
Number of subjects: 12
Study 33279157 — intervention group
Group type: COMPARATOR
Intervention: Both materials tested
Number of subjects: 12
Study 33658470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement comprising 1197 mg of acetic acid bacteria containing 9.06 mg of ceramide
Number of subjects: 30
Study 33658470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32446158 — intervention group
Group type: EXPERIMENTAL
Intervention: Chatbot group (n = 21)
Number of subjects: 41
Study 32446158 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 41
Study 35954756 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Power Training (HIPT)
Number of subjects: 24
Study 35954756 — intervention group
Group type: COMPARATOR
Intervention: Traditional Resistance Training (TRT)
Number of subjects: 24
Study 34911462 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram-1 based on INR and eGFR for 28-day mortality
Number of subjects: 105
Study 34911462 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram-2 based on INR and eGFR for 90-day mortality
Number of subjects: 105
Study 34911462 — intervention group
Group type: COMPARATOR
Intervention: Comparison with AARC, MELD, MELD-Na, and ALBI scores
Number of subjects: 105
Study 34911462 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration curve and Hosmer-Lemeshow test for Nomogram-1 and Nomogram-2
Number of subjects: 105
Study 35065705 — intervention group
Group type: EXPERIMENTAL
Intervention: SCB-2019 vaccine (30 µg, adjuvanted with 1.50 mg CpG-1018 and 0.75 mg alum), administered as two 0.5 mL intramuscular doses 21 days apart.
Number of subjects: 30174
Study 35065705 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride for injection).
Number of subjects: 30174
Study 34412307 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptor-based method combined with partition approach for 3D microstructure reconstruction
Number of subjects: 0
Study 34412307 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D reconstructed model
Number of subjects: 0
Study 32223442 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-affirming implementation intention
Number of subjects: 198
Study 32223442 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental contrasting with self-affirming implementation intention
Number of subjects: 198
Study 32223442 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-affirming implementation intention
Number of subjects: 198
Study 32223442 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group
Number of subjects: 198
Study 33768772 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limb neuromuscular electrical stimulation (NMES)
Number of subjects: 20
Study 33768772 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb neuromuscular electrical stimulation (NMES)
Number of subjects: 20
Study 33768772 — intervention group
Group type: COMPARATOR
Intervention: Comparison of metaboreflex activation between upper and lower limbs
Number of subjects: 20
Study 34941131 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/d
Number of subjects: 46
Study 34941131 — intervention group
Group type: COMPARATOR
Intervention: Bisoprolol 10 mg/d
Number of subjects: 46
Study 34982767 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit/feedback retained, incentives removed (group A)
Number of subjects: 49525
Study 34982767 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives retained, audit/feedback removed (group B)
Number of subjects: 49525
Study 34982767 — intervention group
Group type: EXPERIMENTAL
Intervention: Both removed (group C)
Number of subjects: 49525
Study 34982767 — intervention group
Group type: EXPERIMENTAL
Intervention: Both retained (group D)
Number of subjects: 49525
Study 34982767 — intervention group
Group type: COMPARATOR
Intervention: Audit/feedback removed
Number of subjects: 49525
Study 32683383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonized water treatment
Number of subjects: 51
Study 32683383 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (double‐distilled water)
Number of subjects: 51
Study 36105927 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise (jogging, basketball, and outdoor training) for 12 weeks, three times per week.
Number of subjects: 46
Study 33913549 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin administration
Number of subjects: 991
Study 32861358 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial therapy (3 weeks, 45 minutes per week)
Number of subjects: 65
Study 32861358 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial therapy
Number of subjects: 65
Study 32861358 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 65
Study 34045486 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma containing high titers of neutralizing SARS‐CoV‐2 antibodies (300mL)
Number of subjects: 86
Study 34045486 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 86
Study 32017358 — intervention group
Group type: EXPERIMENTAL
Intervention: ROVOT (robotically operated video optical telescopic-microscope)
Number of subjects: 0
Study 32017358 — intervention group
Group type: COMPARATOR
Intervention: Microscope
Number of subjects: 0
Study 32017358 — intervention group
Group type: EXPERIMENTAL
Intervention: ROVOT
Number of subjects: 0
Study 33951265 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive stenting (TSL >100 mm)
Number of subjects: 1758
Study 33951265 — intervention group
Group type: EXPERIMENTAL
Intervention: Small stenting (ASD <3 mm)
Number of subjects: 1758
Study 33951265 — intervention group
Group type: COMPARATOR
Intervention: Not-extensive and large stents
Number of subjects: 1758
Study 33951265 — intervention group
Group type: EXPERIMENTAL
Intervention: Total stent length (TSL) as a continuous variable
Number of subjects: 1758
Study 33951265 — intervention group
Group type: EXPERIMENTAL
Intervention: Average nominal stent diameter (ASD) as a continuous variable
Number of subjects: 1758
Study 32041656 — intervention group
Group type: COMPARATOR
Intervention: Standard package of support from community health workers (CHWs) during home visits, focused on the individual (Control)
Number of subjects: 0
Study 32041656 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention focusing on both the individual and the household to enable self-management of treatment within an HIV competent household (Intervention)
Number of subjects: 0
Study 34861374 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib monotherapy (300-400 mg twice daily)
Number of subjects: 194
Study 34861374 — intervention group
Group type: COMPARATOR
Intervention: Placebo monotherapy
Number of subjects: 194
Study 34861374 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib during combination therapy and monotherapy
Number of subjects: 194
Study 34861374 — intervention group
Group type: COMPARATOR
Intervention: Veliparib and placebo monotherapy
Number of subjects: 194
Study 35228754 — intervention group
Group type: EXPERIMENTAL
Intervention: empagliflozin 10 mg once daily
Number of subjects: 530
Study 35228754 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 530
Study 32696816 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazilian-Portuguese version of the Sleep Apnea Clinical Score (SACS) applied in 86 patients who underwent polysomnography.
Number of subjects: 106
Study 32696816 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-test phase with consensus version of SACS applied in 20 patients.
Number of subjects: 106
Study 35794587 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron biofortified pearl millet (BPM)
Number of subjects: 0
Study 35794587 — intervention group
Group type: COMPARATOR
Intervention: Standard grain (pearl millet) (CPM)
Number of subjects: 0
Study 34831683 — intervention group
Group type: EXPERIMENTAL
Intervention: Night shift work
Number of subjects: 74
Study 34203356 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted coffee consumption (per 50% increase)
Number of subjects: 53004
Study 35791471 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oligomannate (GV-971)
Number of subjects: 72
Study 35791471 — intervention group
Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 72
Study 33360477 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitspiration
Number of subjects: 331
Study 33360477 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinspiration
Number of subjects: 331
Study 33360477 — intervention group
Group type: COMPARATOR
Intervention: Travel images
Number of subjects: 331
Study 33260699 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational training program for healthcare professionals (20 hours)
Number of subjects: 145
Study 33260699 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 145
Study 33819498 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate 0.03 mg/kg
Number of subjects: 50
Study 33819498 — intervention group
Group type: COMPARATOR
Intervention: Propofol 0.2 mg/kg
Number of subjects: 50
Study 33819498 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Etomidate and Propofol)
Number of subjects: 50
Study 33631623 — intervention group
Group type: EXPERIMENTAL
Intervention: Linseed oil (LO)
Number of subjects: 0
Study 33631623 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil (SO)
Number of subjects: 0
Study 33631623 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm oil (PO)
Number of subjects: 0
Study 33631623 — intervention group
Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 0
Study 33933353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL) treatment, 2 sessions at 3-week intervals
Number of subjects: 76
Study 33933353 — intervention group
Group type: COMPARATOR
Intervention: Sham IPL treatment (Control)
Number of subjects: 76
Study 33225554 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawing therapy
Number of subjects: 48
Study 33225554 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawing therapy (non-randomized comparison)
Number of subjects: 48
Study 33225554 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawing therapy (among those who did not relapse)
Number of subjects: 48
Study 33225554 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawing therapy (in patients with TTN variants)
Number of subjects: 48
Study 36000187 — intervention group
Group type: EXPERIMENTAL
Intervention: Animation education
Number of subjects: 66
Study 36000187 — intervention group
Group type: COMPARATOR
Intervention: Routine face-to-face education
Number of subjects: 66
Study 33586858 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based multimodal exercise program (60-min sessions, three times a week for 16 weeks)
Number of subjects: 40
Study 33586858 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 32498699 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible ureterorenoscopy (FURS)
Number of subjects: 0
Study 32498699 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal shockwave lithotripsy (ESWL)
Number of subjects: 0
Study 32498699 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous nephrolithotomy (PCNL)
Number of subjects: 0
Study 32498699 — intervention group
Group type: EXPERIMENTAL
Intervention: FURS, ESWL, or PCNL
Number of subjects: 0
Study 35995638 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving pressure group (n=650) with alveolar recruitment/individualised PEEP
Number of subjects: 1300
Study 35995638 — intervention group
Group type: COMPARATOR
Intervention: Conventional protective ventilation group (n=650) with fixed PEEP of 5 cm H2O
Number of subjects: 1300
Study 34959836 — intervention group
Group type: EXPERIMENTAL
Intervention: Shatavari (1000 mg/d for 6 weeks)
Number of subjects: 20
Study 34959836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 35662619 — intervention group
Group type: EXPERIMENTAL
Intervention: Reward Re‐Training (RRT) treatment for 10 weeks
Number of subjects: 23
Study 35662619 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 23
Study 32495667 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Magnetic Stimulation (FMS)
Number of subjects: 40
Study 32495667 — intervention group
Group type: COMPARATOR
Intervention: Low-frequency repetitive transcranial magnetic stimulation (LF-rTMS)
Number of subjects: 40
Study 34612491 — intervention group
Group type: EXPERIMENTAL
Intervention: UCT + LNS
Number of subjects: 1729
Study 34612491 — intervention group
Group type: EXPERIMENTAL
Intervention: UCT + LNS + SBCC
Number of subjects: 1729
Study 34612491 — intervention group
Group type: COMPARATOR
Intervention: UCT + SBCC
Number of subjects: 1729
Study 34612491 — intervention group
Group type: COMPARATOR
Intervention: UCT
Number of subjects: 1729
Study 33535507 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (moderate-intensity combined aerobic, resistance and flexibility exercises three times a week for eight weeks)
Number of subjects: 57
Study 33535507 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific information regarding exercise)
Number of subjects: 57
Study 33902773 — intervention group
Group type: EXPERIMENTAL
Intervention: Tier 2 intervention implemented by teachers with training in RtI components
Number of subjects: 1923
Study 33902773 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1923
Study 33902773 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention timing
Number of subjects: 1923
Study 33415859 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (nape seven needles combined with penetration needling for 30 min, once daily for 4 weeks)
Number of subjects: 116
Study 33415859 — intervention group
Group type: COMPARATOR
Intervention: Flunarizine hydrochloride capsules (5 mg, once daily for 4 weeks)
Number of subjects: 116
Study 33415859 — intervention group
Group type: EXPERIMENTAL
Intervention: Total effective rate of treatment group
Number of subjects: 116
Study 35791050 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐d FAST with two 10‐min CWI
Number of subjects: 13
Study 35791050 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐d FAST without CWI
Number of subjects: 13
Study 35791050 — intervention group
Group type: COMPARATOR
Intervention: 2‐d two CWI without FAST
Number of subjects: 13
Study 35791050 — intervention group
Group type: COMPARATOR
Intervention: 2‐d usual diet without CWI
Number of subjects: 13
Study 32501774 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcaftadine 0.25%
Number of subjects: 263
Study 32501774 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 263
Study 32501774 — intervention group
Group type: COMPARATOR
Intervention: Olopatadine 0.1%
Number of subjects: 263
Study 32533236 — intervention group
Group type: EXPERIMENTAL
Intervention: Bracka staged repair (Group A)
Number of subjects: 142
Study 32533236 — intervention group
Group type: COMPARATOR
Intervention: Byar’s staged repair (Group B)
Number of subjects: 142
Study 36260404 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumented shoe insole
Number of subjects: 35
Study 36260404 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 35
Study 34647191 — intervention group
Group type: EXPERIMENTAL
Intervention: RF + PEMF
Number of subjects: 32
Study 34647191 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 32
Study 34762375 — intervention group
Group type: EXPERIMENTAL
Intervention: XingnaoKaiqiao acupuncture (once a day, 5 days per week, for 30 days)
Number of subjects: 100
Study 34762375 — intervention group
Group type: COMPARATOR
Intervention: Control group treatment (rehabilitation and hyperbaric oxygen)
Number of subjects: 100
Study 32424726 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression Garments (CG)
Number of subjects: 30
Study 32424726 — intervention group
Group type: COMPARATOR
Intervention: Control (normal clothing)
Number of subjects: 30
Study 35081935 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile social networking
Number of subjects: 110
Study 35081935 — intervention group
Group type: COMPARATOR
Intervention: Text messaging
Number of subjects: 110
Study 34164935 — intervention group
Group type: EXPERIMENTAL
Intervention: Khanya intervention
Number of subjects: 61
Study 34164935 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Treatment as Usual (ETAU)
Number of subjects: 61
Study 34164935 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study 32293738 — intervention group
Group type: EXPERIMENTAL
Intervention: Oslo Sports Trauma Research Center shoulder injury prevention program (conducted 3 times per week for 18 weeks)
Number of subjects: 57
Study 32293738 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study 32293738 — intervention group
Group type: EXPERIMENTAL
Intervention: Oslo Sports Trauma Research Center shoulder injury prevention program
Number of subjects: 57